Neha Nandedkar-Kulkarni, PhD
Dr. Nandedkar-Kulkarni received her doctorate degree from University of Toledo and joined the Anolik lab as a postdoctoral fellow in 2019. During her time in the lab she examined targeting autoreactive plasma cells in human SLE using selective inhibitors of nuclear export (SINE). She is presently working as a Scientist in Immunology, Drug Discovery and Autoimmunity at Sanofi.
Ms. Bird was a pre-doctoral student in the Immunology, Microbiology and Virology (IMV) Ph.D. Program. Her Ph.D. project examined the contribution of neutrophils to lupus pathogenesis in a murine model of lupus and lupus patients. She graduated in 2017 and currently holds a senior scientist position at AstraZeneca.
Diana Adlowitz, Ph.D.
Dr. Aldowitz joined the Anolik lab as a postdoctoral associate from 2011-2013. Her project included characterization of memory B cells in RA patients treated with B cell depletion therapy. She is currently a staff scientist at the Department of Pathology and Laboratory Medicine, URMC.
Arumugam (Aru) Palanichamy, Ph.D.
Dr. Palanichamy worked in the Anolik lab as postdoctoral fellow from 2007-2012. His research focus was to investigate B cell abnormalities in systemic lupus erythematosus (SLE) and rheumatoid arthritis. He delineated a late transitional B cell subset in humans with implications for SLE and reported a previously unrecognized type I IFN activation in the bone marrow of human SLE. Currently, he is a Senior Director at Avalo Therapeutics.
Wensheng Wang, Ph.D.
Dr. Wang joined the Anolik Lab as a postdoctoral associate from 2009-2011. His project involved studying the long0term B cell depletion in murine lupus and its effect on autoantibody secreting plasma cells.
H. Travis Ichikawa, Ph.D.
During his postdoctoral training in the Anolik lab from 2008-2010, Dr. Ichikawa studied the effects of novel proteasome inhibitors in murine lupus.